SANA
Sana Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.85
−1.79%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-137.0%
Return on equity
-49.1%
Return on assets
-91.1%
Return on invested capital
0.00x
Asset turnover
-$132.2M
Cash from operations
$0.54
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026